{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"147","upperLimit":"147","value":"147"},{"groupId":"OG001","lowerLimit":"29","upperLimit":"115","value":"72"},{"groupId":"OG002","lowerLimit":"68","upperLimit":"557","value":"313"},{"groupId":"OG003","lowerLimit":"50","upperLimit":"148","value":"99"},{"groupId":"OG004","lowerLimit":"56","upperLimit":"391","value":"141"},{"groupId":"OG005","lowerLimit":"67","upperLimit":"588","value":"307"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"5"}],"units":"Participants"}],"description":"The time period from the response achieved in patient until the disease progression.","dispersionType":"Full Range","groups":[{"description":"RP6530 administered 200 mg orally twice a day.","id":"OG000","title":"Dose escalation_Cohort 1_200 mg"},{"description":"RP6530 administered 400 mg orally twice a day.","id":"OG001","title":"Dose escalation_Cohort 2_400 mg"},{"description":"RP6530 administered 800 mg orally twice a day under fasting condition","id":"OG002","title":"Dose escalation_Cohort 3_800 mg (Fasting)"},{"description":"RP6530 administered 800 mg orally twice a day under fed condition","id":"OG003","title":"Dose escalation_Cohort 4_800 mg (Fed)"},{"description":"RP6530 administered 800 mg orally twice a day under fasting condition","id":"OG004","title":"Dose expansion_PTCL_800 mg (Fasting)"},{"description":"RP6530 administered 800 mg orally twice a day under fasting condition","id":"OG005","title":"Dose expansion_CTCL_800 mg (Fasting)"}],"paramType":"MEDIAN","populationDescription":"Duration of Response (DoR) is defined as the time when the measurement criteria are first met for PR or CR (whichever is reported first) until the date of documented disease progression or death. Overall number of Participants analyzed for DoR will be the participants who met response as CR or PR","reportingStatus":"POSTED","timeFrame":"24 months","title":"Duration of Response (DOR) With RP6530","type":"SECONDARY","unitOfMeasure":"Days"}